|
Volumn 26, Issue 3, 2008, Pages 254-255
|
Start-ups weigh benefits of corporate incubators
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
ACADEMIC ACHIEVEMENT;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
FINANCIAL MANAGEMENT;
INCUBATOR;
INFORMATION TECHNOLOGY;
NOTE;
PRIORITY JOURNAL;
BIOTECHNOLOGY;
CAPITAL FINANCING;
COMMERCE;
DECISION MAKING, ORGANIZATIONAL;
ECONOMIC COMPETITION;
EFFICIENCY, ORGANIZATIONAL;
UNITED STATES;
|
EID: 40449117971
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0308-254 Document Type: Note |
Times cited : (3)
|
References (0)
|